Jazz Venture Partners

Startup Raises $3M to Help Displaced Workers Transition to the Health Care Economy | PR Newswire | 8/1/2019

SEATTLE , Aug. 1, 2019 /PRNewswire/ – NextStep Interactive , a startup that aims to help displaced workers retrain for fast-growing careers in the health care sector today announced a $3 million investment from education and impact investors including SEI Ventures, JAZZ Venture Partners, Learn Capital’s LearnStart fund, Springrock Ventures, City Light Capital, Frontier Angels, and three managing directors of Pioneer Square Labs. NextStep, a spinout of Pioneer Square Labs, the Seattle …

Global Sports and Fitness Apps Market is Expected to exhibit a CAGR of 20.4% During the Forecast Period (2019-2027) | PR Newswire | 7/12/2019

SEATTLE , July 12, According to Coherent Market Insights, the global sports and fitness apps market is projected to exhibit an impressive CAGR of 20.4% over the forecast period (2019–2027). Key Trends and Analysis of the Global Sports and Fitness Apps Market: Increase in adoption of health and fitness apps, owing to rising fitness-consciousness among individuals is expected to fuel growth of the sports and fitness apps market. Increase …

Follow Jazz Venture Partners:    

Digital health investments bounced back in Q2 2019 with nearly $2.5B in funding | MobiHealthNews | 7/5/2019

… care programmes from 100 reputed hospitals practice across 20 specialties in India. Series A $15.90 UCHealth, University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investors The new infusion of cash will be put towards growing the company’s platform and technology. The company’s platform, called SwiftRX, uses machine learning to help doctors choose which medication to …

Chicago startup Level Ex brings video games to the world of medicine - MedCity News | 6/10/2019

… products included in specific games. For instance, one game lets users practice dosing Suprane, an anesthetic from Pfizer. Since its inception, the startup has also secured funding from investors like OSF Ventures , 4490 Ventures, JAZZ Venture Partners and Pritzker Group Venture Capital . Photo: Level Ex …

The Funded: 9 Bay Area startups raised over $300M at week’s end | The Business Journals | 6/7/2019

… valued at about $71 million, having raised about $47 million in equity funding to date from Scout Ventures, Vision Ridge Partners and Joanne Wilson. Read more here. Funders in the news San Francisco-based Jazz Venture Partners has raised a $287 million in capital commitments from 83 backers, according to an SEC filing . Ranked by Silicon Valley VC deals in 2018 Rank Silicon Valley VC deals in 2018 1 Plug …

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

… lands $15.9M, former Cleveland Clinic CEO joins board UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in Series A funding. UCHealth led the funding …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

… funding round. Colorado-based health system UCHealth led the round. Participation also came from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and other existing investors. Founded in 2013, the startup offers a SwiftRx platform, which includes three solutions . One is SwiftRx Direct, a cost transparency tool that brings cost information, coverage restrictions and therapeutic …

RxRevu - the Industry Leader in Prescription Decision Support - Secures $15.9 Million in Series A Funding Led by UCHealth | PR Newswire | 6/4/2019

… million . The round was led by Colorado -based nonprofit health system, UCHealth. Additional investors include University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investors. Through its SwiftRx ® platform and underlying suite of Prescription Decision Support tools, RxRevu’s EHR-integrated technology allows healthcare professionals to make more informed prescribing decisions by considering everything from a …

Despite Investor Rejection, This Single Mom Scientist Raised $58 Million To Make Hiring Less Biased | Forbes | 5/9/2019

Frida Polli has raised tens of millions of dollars to transform the way we find and hire for jobs. Her SaaS company, pymetrics, creates custom algorithms that are now being used by leading companies and professionals to find a better candidate-job fit. In her exclusive interview on the DealMakers Podcast , she shared her take on brain science, the latest stats for women entrepreneurs, how to overcome adversity in fundraising …

Digital health funding hits $1.4B in 2019’s first quarter | MobiHealthNews | 4/5/2019

Digital health funding hits $1.4B in 2019’s first quarter Clover Health topped the charts with a round pegged at $500 million. April 05, 2019 Share Kicking off the year MobiHealthNews recorded $1.4 billion in Q1 funding spread out over 49 companies. This number exceeded the amount of last year’s Q1 funding , which came in at $1.2 billion. Earlier this week Rock Health released its funding report for the quarter …

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M | Seeking Alpha | 1/6/2018

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M Series B round in Personal Genome Diagnostics (PGDx), a cancer diagnostics startup. New Enterprise Associates also led and was joined by Co-win Healthcare Fund, Helsinn Investment Fund, Inova Strategic Investments, the Maryland Venture Fund, and Windham Venture Partners. The round brings PGDx up to $99.3M in total funding, according to Crunchbase. PGDx will use the funding to develop an …

PEAR Therapeutics Completes $50 Million Series B Financing | Morningstar | 1/2/2018

PEAR Therapeutics Completes $50 Million Series B Financing Temasek Joins Current Investors to Advance Prescription Digital Therapeutics Platform PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that it has successfully closed a $50 million Series B financing led by Temasek. With this financing, Temasek joins new and existing investors including 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, Singapore-based EDBI, and the Bridge Builder’s Collaborative. PEAR is …

Prescription Decision Support

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

Search Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in Series …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

Startups UCHealth leads $15.9M round for prescription decision support startup RxRevu Other investors in the Series A round included the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado-based company focused on prescription decision support, has wrapped up a $15.9 million Series A …

Digital Therapeutics

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M | Seeking Alpha | 1/6/2018

… Digital therapeutics: Novartis (NYSE: NVS ) was among the investors in a $50M Series B round for prescription digital therapeutics developer Pear Therapeutics. Temasek led the round with other new and returning investors 5AM Ventures, Arboretum Ventures, the Bridge Builder’s Collaborative, JAZZ Venture Partners, and EDBI. The round brings total funding up to $70M. Pear Therapeutics received FDA approval last September for its reSET application, which was “the first mobile medical …

PEAR Therapeutics Completes $50 Million Series B Financing | Morningstar | 1/2/2018

PEAR Therapeutics Completes $50 Million Series B Financing Temasek Joins Current Investors to Advance Prescription Digital Therapeutics Platform PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that it has successfully closed a $50 million Series B financing led by Temasek. With this financing, Temasek joins new and existing investors including 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, Singapore-based EDBI, and the Bridge Builder’s Collaborative. PEAR is …

RxREVU

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

Search Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in Series …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

Startups UCHealth leads $15.9M round for prescription decision support startup RxRevu Other investors in the Series A round included the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado-based company focused on prescription decision support, has wrapped up a $15.9 million Series A …

Pear Therapeutics

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M | Seeking Alpha | 1/6/2018

Pear Therapeutics. Temasek led the round with other new and returning investors 5AM Ventures, Arboretum Ventures, the Bridge Builder’s Collaborative, JAZZ Venture Partners, and EDBI. The round brings total funding up to $70M. Pear Therapeutics received FDA approval last September for its reSET application, which was “the first mobile medical application to help treat substance use disorders.” The app is used in conjunction with outpatient therapy for alcohol, cocaine, marijuana …

PEAR Therapeutics Completes $50 Million Series B Financing | Morningstar | 1/2/2018

PEAR Therapeutics Completes $50 Million Series B Financing Temasek Joins Current Investors to Advance Prescription Digital Therapeutics Platform PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that it has successfully closed a $50 million Series B financing led by Temasek. With this financing, Temasek joins new and existing investors including 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, Singapore-based EDBI, and the Bridge Builder’s Collaborative. PEAR is …

Novartis

Digital health funding hits $1.4B in 2019’s first quarter | MobiHealthNews | 4/5/2019

Novartis, 5AM Ventures, Arboretum Ventures, Jazz Venture Partners, The Bridge Builders Collaborative and EDBI The new money is set to help the company globalize the commercialization of the reSET suite of productsówhich were first commercially launched in November. The Boston-based company makes prescription software-based treatments Northpond Ventures, Section 32, Founders Fund, Sands Capital Ventures and Borealis Ventures The company will continue development of its platform and international expansion …

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M | Seeking Alpha | 1/6/2018

Novartis (NYSE: NVS ) was among the investors in a $50M Series B round for prescription digital therapeutics developer Pear Therapeutics. Temasek led the round with other new and returning investors 5AM Ventures, Arboretum Ventures, the Bridge Builder’s Collaborative, JAZZ Venture Partners, and EDBI. The round brings total funding up to $70M. Pear Therapeutics received FDA approval last September for its reSET application, which was “the first mobile medical application to …

Arboretum Ventures

Digital health funding hits $1.4B in 2019’s first quarter | MobiHealthNews | 4/5/2019

Arboretum Ventures, Jazz Venture Partners, The Bridge Builders Collaborative and EDBI The new money is set to help the company globalize the commercialization of the reSET suite of productsówhich were first commercially launched in November. The Boston-based company makes prescription software-based treatments Northpond Ventures, Section 32, Founders Fund, Sands Capital Ventures and Borealis Ventures The company will continue development of its platform and international expansion. Teckro’s digital offering …

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M | Seeking Alpha | 1/6/2018

Arboretum Ventures, the Bridge Builder’s Collaborative, JAZZ Venture Partners, and EDBI. The round brings total funding up to $70M. Pear Therapeutics received FDA approval last September for its reSET application, which was “the first mobile medical application to help treat substance use disorders.” The app is used in conjunction with outpatient therapy for alcohol, cocaine, marijuana, and stimulant substance abuse disorders but not for opioid treatment. The company’s pipeline includes …

5AM Ventures

Digital health funding hits $1.4B in 2019’s first quarter | MobiHealthNews | 4/5/2019

5AM Ventures, Arboretum Ventures, Jazz Venture Partners, The Bridge Builders Collaborative and EDBI The new money is set to help the company globalize the commercialization of the reSET suite of productsówhich were first commercially launched in November. The Boston-based company makes prescription software-based treatments Northpond Ventures, Section 32, Founders Fund, Sands Capital Ventures and Borealis Ventures The company will continue development of its platform and international expansion. Teckro’s …

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M | Seeking Alpha | 1/6/2018

5AM Ventures, Arboretum Ventures, the Bridge Builder’s Collaborative, JAZZ Venture Partners, and EDBI. The round brings total funding up to $70M. Pear Therapeutics received FDA approval last September for its reSET application, which was “the first mobile medical application to help treat substance use disorders.” The app is used in conjunction with outpatient therapy for alcohol, cocaine, marijuana, and stimulant substance abuse disorders but not for opioid treatment. The company’s …

HCA

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

Search Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in Series …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

Startups UCHealth leads $15.9M round for prescription decision support startup RxRevu Other investors in the Series A round included the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado-based company focused on prescription decision support, has wrapped up a $15.9 million Series A …

Cleveland Clinic, Cleveland OH

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

Search Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in Series …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

… University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado … of directors: UCHealth chief innovation officer Richard Zane and former Cleveland Clinic CEO Toby Cosgrove. Other companies have also been working to improve prescription price transparency. For instance, earlier this year health IT vendor Cerner …

Children's Hospital Colorado

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

… 15.9M, former Cleveland Clinic CEO joins board UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in Series A funding. UCHealth led the funding with …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

Startups UCHealth leads $15.9M round for prescription decision support startup RxRevu Other investors in the Series A round included the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado-based company focused on prescription decision support, has wrapped up a $15.9 million Series A …

Cleveland Clinic

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

Search Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in Series …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

… University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado … of directors: UCHealth chief innovation officer Richard Zane and former Cleveland Clinic CEO Toby Cosgrove. Other companies have also been working to improve prescription price transparency. For instance, earlier this year health IT vendor Cerner …

UnityPoint Health

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

Search Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in Series …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

Startups UCHealth leads $15.9M round for prescription decision support startup RxRevu Other investors in the Series A round included the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado-based company focused on prescription decision support, has wrapped up a $15.9 million Series A …

Presbyterian Healthcare Services

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

Search Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in Series …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

Startups UCHealth leads $15.9M round for prescription decision support startup RxRevu Other investors in the Series A round included the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado-based company focused on prescription decision support, has wrapped up a $15.9 million Series A …

Toby Cosgrove

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

… from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which … Richard Zane, the chief innovation officer at UCHealth and Dr. Toby Cosgrove, executive advisor at Cleveland Clinic, will be joining the board of directors. WHAT THEY DO The company’s platform, called SwiftRX, uses machine learning …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

… University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado … chief innovation officer Richard Zane and former Cleveland Clinic CEO Toby Cosgrove. Other companies have also been working to improve prescription price transparency. For instance, earlier this year health IT vendor Cerner and CoverMyMeds, which …

Richard Zane

Prescription decision support platform RxRevu lands $15.9M, former Cleveland Clinic CEO joins board | MobiHealthNews | 6/6/2019

… from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investor June 06, 2019 Share Colorado-based startup RxRevu, which … Partners and existing investors. As part of the announcement Dr. Richard Zane, the chief innovation officer at UCHealth and Dr. Toby Cosgrove, executive advisor at Cleveland Clinic, will be joining the board of directors. WHAT …

UCHealth leads $15.9M round for prescription decision support startup RxRevu - MedCity News | 6/5/2019

… University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health and JAZZ Venture Partners. Post a comment / at 11:58 AM Shares 0 RxRevu , a Denver, Colorado … additions to its board of directors: UCHealth chief innovation officer Richard Zane and former Cleveland Clinic CEO Toby Cosgrove. Other companies have also been working to improve prescription price transparency. For instance, earlier this year …

Corey McCann

PEAR Therapeutics Completes $50 Million Series B Financing | Morningstar | 1/2/2018

… Series B financing led by Temasek. With this financing, Temasek joins new and existing investors including 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, Singapore-based EDBI, and the Bridge Builder’s Collaborative. PEAR is the … efficacy of our therapeutics across a variety of indications,” said Corey McCann, M.D., Ph.D., President and CEO of PEAR Therapeutics. “This latest financing recognizes the strides we’ve made in proving the clinical utility and commercial …

PEAR Therapeutics Completes $50 Million Series B Financing | Business Wire | 1/2/2018

… Series B financing led by Temasek. With this financing, Temasek joins new and existing investors including 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, Singapore-based EDBI, and the Bridge Builder’s Collaborative. PEAR is the … efficacy of our therapeutics across a variety of indications,” said Corey McCann, M.D., Ph.D., President and CEO of PEAR Therapeutics. “This latest financing recognizes the strides we’ve made in proving the clinical utility and commercial …